INSIGHTS ON MANUFACTURING LOGISTICS

• Innovative Preservation Solutions For Cell Therapy

  The low efficiency and poor biocompatibility of conventional preservatives hinder successful cell preservation. Explore solutions to enhance the stability and post-thaw viability of cell therapy products.

• Unlocking The Potential Of Your Sterile Injectables With Exact SI-ence

  Sterile injectables present multiple hurdles on the path from early clinical phases to commercial. Learn how a partner with extensive capabilities and expertise can help streamline the path to market.

• Extractables And Leachables Testing

  Learn how to navigate the extractables and leachables regulatory landscape and implement best practices for leachables analysis in your pharmaceutical development process.

• Reducing Product Loss In The Biomanufacturing Cold Chain

  Traditional single-use bags are vulnerable to damage at multiple points in the cold chain. Learn about flexible containers that minimize the risk and bring strength and durability to your cold chain.

• Selecting Container Closure Systems With Confidence: Lyophilization

  3/7/2024

  Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

• Safe Handling Of Monoclonal Antibodies: Best Practices

  3/7/2024

  Explore safety measures for handling mAbs in production in order to meet strict requirements that prevent contamination, product loss and exposure to cytotoxic agents or radioisotopes.

• End-To-End Cold Chain Management: A Next-Generation Approach

  2/26/2024

  Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.

• Cryopreservation Best Practices For Cell & Gene Therapy Source Material

  2/26/2024

  Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.

• The Use Of Injectable Packaging From Early Development To Commercialization

  2/20/2024

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.